Dearborn Partners LLC Merck & Co., Inc. Transaction History

Dearborn Partners LLC

  • $2.28 Billion
  • Q2 2024

A detailed history of Dearborn Partners LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Dearborn Partners LLC holds 290,989 shares of MRK stock, worth $34.3 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares
290,989
Previous 293,600 0.89%
Holding current value
$34.3 Million
Previous $38.7 Million 7.01%
% of portfolio
1.58%
Previous 1.69%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024
SELL
$123.8 - $132.96 $323,241 - $347,158
-2,611 Reduced 0.89%
290,989 $36 Million
Q1 2024

May 08, 2024
SELL
$113.24 - $131.95 $12.3 Million - $14.4 Million
-108,768 Reduced 27.03%
293,600 $38.7 Million
Q4 2023

Jan 26, 2024
SELL
$100.18 - $109.02 $856,138 - $931,684
-8,546 Reduced 2.08%
402,368 $43.9 Million
Q3 2023

Nov 01, 2023
BUY
$102.95 - $114.33 $102,126 - $113,415
992 Added 0.24%
410,914 $42.3 Million
Q2 2023

Aug 03, 2023
SELL
$108.61 - $118.38 $10.7 Million - $11.7 Million
-98,752 Reduced 19.41%
409,922 $47.3 Million
Q1 2023

May 04, 2023
BUY
$102.94 - $114.86 $88,116 - $98,320
856 Added 0.17%
508,674 $54.1 Million
Q4 2022

Feb 02, 2023
SELL
$87.44 - $112.11 $405,459 - $519,854
-4,637 Reduced 0.9%
507,818 $56.3 Million
Q3 2022

Oct 25, 2022
BUY
$84.53 - $94.96 $180,048 - $202,264
2,130 Added 0.42%
512,455 $44.1 Million
Q2 2022

Jul 20, 2022
SELL
$83.49 - $94.64 $138,843 - $157,386
-1,663 Reduced 0.32%
510,325 $46.5 Million
Q1 2022

May 04, 2022
BUY
$73.51 - $82.4 $1.05 Million - $1.18 Million
14,283 Added 2.87%
511,988 $42 Million
Q4 2021

Jan 28, 2022
BUY
$72.28 - $90.54 $222,333 - $278,501
3,076 Added 0.62%
497,705 $38.1 Million
Q3 2021

Oct 27, 2021
BUY
$71.68 - $78.83 $13.4 Million - $14.8 Million
187,443 Added 61.02%
494,629 $37.2 Million
Q2 2021

Jul 26, 2021
SELL
$70.31 - $77.77 $21.5 Million - $23.8 Million
-306,057 Closed
0 $0
Q1 2021

Apr 29, 2021
BUY
$68.86 - $81.11 $407,995 - $480,576
5,925 Added 1.97%
306,057 $23.6 Million
Q4 2020

Jan 27, 2021
BUY
$71.77 - $79.65 $267,486 - $296,855
3,727 Added 1.26%
300,132 $24.6 Million
Q3 2020

Oct 20, 2020
BUY
$73.18 - $82.95 $76,839 - $87,097
1,050 Added 0.36%
296,405 $24.6 Million
Q2 2020

Jul 30, 2020
SELL
$70.42 - $80.13 $527,164 - $599,853
-7,486 Reduced 2.47%
295,355 $22.8 Million
Q1 2020

May 11, 2020
BUY
$63.36 - $87.82 $551,675 - $764,648
8,707 Added 2.96%
302,841 $23.3 Million
Q4 2019

Jan 28, 2020
BUY
$77.58 - $87.54 $1.3 Million - $1.47 Million
16,751 Added 6.04%
294,134 $26.8 Million
Q3 2019

Oct 29, 2019
BUY
$76.08 - $82.93 $317,710 - $346,315
4,176 Added 1.53%
277,383 $23.4 Million
Q2 2019

Jul 29, 2019
BUY
$69.84 - $81.59 $691,555 - $807,904
9,902 Added 3.76%
273,207 $22.9 Million
Q1 2019

May 01, 2019
BUY
$69.58 - $79.36 $420,819 - $479,969
6,048 Added 2.35%
263,305 $21.9 Million
Q4 2018

Feb 04, 2019
BUY
$65.24 - $75.71 $205,049 - $237,956
3,143 Added 1.24%
257,257 $19.7 Million
Q3 2018

Oct 24, 2018
BUY
$57.69 - $67.84 $161,589 - $190,019
2,801 Added 1.11%
254,114 $18 Million
Q2 2018

Aug 14, 2018
SELL
$50.83 - $59.72 $660,078 - $775,523
-12,986 Reduced 4.91%
251,313 $15.3 Million
Q1 2018

May 01, 2018
SELL
$50.96 - $59.23 $448,142 - $520,868
-8,794 Reduced 3.22%
264,299 $14.4 Million
Q4 2017

Feb 02, 2018
SELL
$51.62 - $61.64 $442,693 - $528,624
-8,576 Reduced 3.04%
273,093 $15.4 Million
Q3 2017

Nov 13, 2017
SELL
$58.67 - $63.13 $34,732 - $37,372
-592 Reduced 0.21%
281,669 $18 Million
Q2 2017

Aug 09, 2017
BUY
N/A
282,261
282,261 $18.1 Million

Others Institutions Holding MRK

# of Institutions
3,825
Shares Held
1.91B
Call Options Held
13.4M
Put Options Held
10.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $299B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Dearborn Partners LLC Portfolio

Follow Dearborn Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email